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ABSTRACT 
 
Background: Bisphosphonates have been used in the treatment of osteoporosis, hypercalcemia of malignancy, 
bone metastasis and osteopenia control. Simultaneous use of bisphosphonates with the dental surgical 
procedures increases the risk of osteonecrosis in the patients.  
 
Aim: The aim of this study was to determine the knowledge rate of general dentists in Ardabil Province regarding 
dental considerations in the patients using bisphosphonate.  
 
Methods: In this descriptive cross-sectional trial, 116 general dentists were selected and studied by a 
questionnaire included demographic items and knowledge about dental considerations among patients using 
bisphosphonate. The knowledge scores were classified in 3 groups of weak; moderate and good and collected 
data analyzed by statistical methods in SPSS.19.  
 
Results: The mean knowledge of the dentists was 14±3.9. Moderate knowledge was seen among 50.9% of 
dentists. There wasn’t significant relation between sex and knowledge rate.  However, dentists with the ages 
under 30 years old showed 3 fold more frequency of good knowledge compared to the dentists over 30 years old 
(p=0.001).  
 
Conclusion: Results showed that dentists have proper knowledge regarding dental considerations among the 
patients using bisphosphonates; Due to the importance of preventions of osteonecrosis risk factors following 
using bisphosphonates; more instructions are required in this field. 
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INTRODUCTION  
 
Bisphosphonates have been used in the treatment 
of osteoporosis, hyperkalemia of malignancy, bone 
metastasis, osteopenia control and Paget’s disease. 
Despite the health benefits of these drugs, recently 
osteonecrosis of the jaws to be mentioned as a 
serious complication in patients taking them. Bis-
Phosphonate related osteonecrosis of the jaw 
(BRONJ) first proposed in 2003 by Marx and 
reports of the disease cases are on the rise today 
[1-7]. 
 
In various studies, the risk factors related to the 
occurrence of BRONJ include dentoalveolar trauma 
history and duration use of bisphosphonates which 
dentoalveolar trauma history has been the most 
common between them [8-10]. 
 
Patients, who received intravenous 
bisphosphonates as compared to patients taking 
oral medication, are more susceptible to BRONJ. 
Concomitant use of corticosteroids increases the 
risk of BRONJ.  
 
The major risk factor in the development of BRONJ 
is use of bisphosphonate and its administration 
method.  (0.01-0.04% of oral intake and 0.8-12% on 
intravenous administration) [11]. 
 
In order to prevent the occurrence of osteonecrosis 
of the jaws, it is necessary for dentists to consider 
the consumer of these drugs. There is no doubt in 
the case of preventive measures by dentists; the 
occurrence of this dangerous disease is prevented. 
The present study determined the knowledge of 
general dentists in Ardabil Province regarding 
dental considerations in the patients using 
bisphosphonate. 
 
MATRIALS AND METHODS 
 
In this Cross-sectional descriptive study, 116 
general dentists were selected and studied by a 
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questionnaire included demographic items and 
knowledge about dental considerations among 
patients using bisphosphonate. All questions was 
score by Likert from 1 to 5 and the total knowledge 
score were classified in 3 groups of weak (7-12); 
moderate (12-17) and good (>17). Collected data 
analyzed by descriptive and analytical statistical 
methods and Chi-Square test in SPSS.19. P<0.05 
was considered as significant.  
 
RESULTS 
 
The mean of dentist’s duration of employment was 
8.6±8 (range 1-35 years) and 64.7% of dentists 
have duration of employment lower than 10 years.  
 
The mean age of dentists was 36.2±9 (range 24-60) 
and 69% of dentists were >30 years. The mean 
knowledge of dentists was 14±3.9 (range7-23) and 
50.9% of dentists have moderate knowledge. 
(Figure 1) 
 
Figure 1: The rate of knowledge of dentists 
about dental procedures in patients taking 
bisphosphonate drugs 
 
 
The rate of good knowledge in dentists with >10 
years duration of employee compare to other 
dentists was up but not statistically significant. 
(Table 1) 
 
Table 1: Knowledge rate of dentists by Duration 
of employee 
Knowledge 
rate 
Weak Moderate Good 
Duration of 
employee 
n % n % n % 
< 10 yr 21 61.8 34 57.6 20 8.7 
10-20 yr 9 26.5 19 32.2 2 8.7 
>20 yr 4 11.8 6 10.2 1 4.3 
Total 34 29.3 59 50.9 23 19.8 
P=0.54 
 
There was a significant relation between age and 
knowledge rate, because the good knowledge rate 
in dentists with up > 30 years age was 73.9% that 
about three more than other dentists. (Table 2) 
 
Table 2: Knowledge rate of dentists by age 
Knowledge rate Week Moderate Good 
Age group n % n % n % 
<30 yr 4 11.8 15 25.4 17 73.9 
>30 yr 30 88.2 44 74.6 6 26.1 
Total 34 29.3 59 50.9 23 19.8 
P=0.001 
 
There wasn’t significant relation between sex and 
knowledge rate and the rate of all knowledge levels 
in women proportionally higher than men. (Table 3) 
 
Table 3: Knowledge rate of dentists by sex 
Knowledge rate Week Moderate Good 
Sex n % n % n % 
Male 9 26.5 28 47.5 10 43.5 
Female 25 73.5 31 52.5 13 56.5 
Total 34 29.3 59 50.9 23 19.8 
P=0.42 
 
DISCUSSION 
 
There are many case studies (case-report) and 
case series on the complication of osteonecrosis of 
the jaw (BRONJ) in the research backgrounds [12-
16]. 
 
According to result of this study, we can say that 
dentists have appropriate knowledge about dental 
procedures in patients taking bisphosphonates, 
although some weaknesses were found in this area. 
The prevalence of BRONJ in patients with 
intravenous bisphosphonates was 0.8-1.2% and in 
patients with oral use was 0.00038-.06% [17-18]. 
 
Diagnosis of BRONJ not possible easily and may 
be due to conditions associated with surgery of the 
mouth area as well as any diagnostics done [19]. 
Therefore, correct diagnosis BRONJ, in cases of 
bisphosphonate use is necessary.  
 
Despite the importance of subjective symptoms in 
patients with BRONJ (bad breath and difficulty 
eating and speaking), only 53.4% of dentists know 
these symptoms. 
 
BRONJ lesions appear in radiography as lucent 
which 48.3% of dentists known this. The most 
common clinical complication of BRONJ is injured 
that exposed the underlying bone and 45.7% of 
dentists true reported to its. BRONJ not respond 
well to different treatments and, therefore, 
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prevention and early diagnosis of disease is 
importance and 42.2% of dentists known it [17]. 
 
In Lopez-Jornet and et al study in 2010, only 13.3% 
of students and 33.3% of dentists have sufficient 
information about osteonecrosis treatment [20].  
 
It seems in treatments with bone exposes such as 
removal teeth and Placement of dental implants, 
preparation of the patient's history of medications is 
extremely important so that we can reduce the risk 
of BRONJ. 
 
Bisphosphonate drugs are prescribed for the 
treatment of bone diseases such as osteoporosis, 
multiple bone metastases, multiple myeloma and 
Paget's disease [13]. 
 
In this research, 64.7% of dentists reported to the 
use of bisphosphonate in treatment osteoporosis 
disease and 53.4% to the treatment of cancer 
patients.  
 
Some of dental students and dentists not knew the 
medical indications of bisphosphonate drugs [20-
21].  
 
Lopez-Jornet and et al in a study reported that only 
30% of dental students and 51.6% of dentists have 
known about indications of bisphosphonate drugs 
[20].  
 
Because of possible side effect of taking 
bisphosphonates is BRONJ, dentists should be 
aware of the mechanism of action of these drugs.  
 
De Lima and et al in a study showed that 59.6% of 
dentists and 58% of dental students haven’t 
knowledge about this topic and these findings 
concern [21]. 
 
Dentoalveolar area surgery is a risk factor for 
osteonecrosis of the jaw, so that if a complication 
BRONJ had been seen in a radiography of patient 
we must not out of his teeth which 65.5% of dentists 
had known it. Also, we must note that in the need 
for taking bisphosphonates after invasive dental 
procedures, this must be done after 6 weeks that 
31.9% of dentists have enough knowledge about it. 
Periodontal diseases and the use of denture or 
implant placement can also be risk factors for 
prevalence BRONJ which 70.7% of dentists known 
this subject [14-15]. 
 
According to our research, 74% of dentists pointed 
to the increased risk of BRONJ after concomitant 
use of steroids with bisphosphonates and 49.1% 
know that the Susceptibility to BRONJ in patients 
receiving bisphosphonates drugs intravenously (IV) 
was more than other methods and 71.6% truly 
pointed to incidence of BRONJ after teeth removal.  
 
45.7% of dentists known the mean time for 
treatment start to necrosis producing in cancer 
patients or IV injection bisphosphonates which 
similar to other research [22-24]. 
The rate of good knowledge in dentist under 30 
years old with 73.9% about three times was 
significantly more than other dentists. Mah and et al 
in study showed that the dentists in age group 25-
35 have the upper knowledge rate which was 
similar to our study results and also, other results of 
our study were similar to Mah and et al study [25]. 
 
The main purpose of referring patients taking 
bisphosphonate drugs maxillofacial specialists, 
prevent or reduce the risk of BRONJ in susceptible 
individuals. There is no doubt treatment of dental 
surgery in patients taking bisphosphonate drugs 
can complain about the dentist and to pursue the 
matter through legal channels as well as in these 
cases, the problems will create to the dentist. 
 
Better information of health service providers on 
bisphosphonate drugs, can reduce the incidence of 
BROJN and appropriate recovery of patients to be 
followed [26-27]. 
 
On the other hand, improve patient education about 
how to use and side effects of bisphosphonate 
drugs by doctors and dentists will lead to improve 
the quality of medical care and reduce 
complications associated with medical and dental 
treatments [24]. 
 
CONCLUSION  
 
The results showed that dentists had appropriate 
knowledge about dental procedures in patients 
taking bisphosphonates. Because of the importance 
of the prevention of the risk factors of osteonecrosis 
complication after taking bisphosphonate, more 
education must be provided about this topic to the 
dentists. 
 
Before dental procedures in patients taking 
bisphosphonate drugs, dentists should be done 
complete dental and oral assessments of patients, 
learn methods of disease prevention and oral health 
and the risk of such drugs to them. 
 
The lack of opportunities for learning how to 
perform dental procedures on consumer’s 
bisphosphonate drugs and other reasons can lead 
to low knowledge of dentists. So, we must increase 
awareness of general dentists on this topic by 
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organizing courses and the study of articles 
published in this issue. 
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